international reference pricing: there are better options to address patients’ drug costs
Published 3 years ago • 1.2K plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
59:55
webinar: international reference pricing – a failed strategy for patients and innovation?
-
2:10
how will medicare negotiate drug prices? what patients need to know
-
44:35
getting it right: drug pricing reform that works for patients and the medicare program
-
54:45
panel 3: a value-based approach to drug pricing (unpacking drug value) | kaiser permanente
-
44:55
research!america discussion with sue peschin, mhs, president & ceo, alliance for aging research
-
1:00:32
nmqf webinar: the structural components of equity: prescription drug pricing
-
1:36:08
asbm/gabi webinar- medicare drug price negotiation: impacts on innovation and patient access
-
5:40:26
2024 pqm msr recommendation group measure review meeting day 1 (9/30/24)
-
25:55
usa vs europe: the deadly difference of prescription drug pricing | 2023 comparison
-
2:25:40
feeling the squeeze: prescription drug pricing trends and options for state legislators
-
1:32:12
policy dialogue the revision of the eu regulations on medicines for children and rare diseases
-
1:31:01
unpacking policy options to promote prescription drug affordability
-
1:20:35
lessons from international experience in determining health care prices part 3
-
1:36:02
under the dome: issues and policies impacting patient consumer choice and access to treatments
-
1:23:36
advancing generic drug development: translating science to approval 2023 – day 1 – part 1
-
1:02:50
vital signals: kidney stakeholder policy priorities impacting patients
-
1:30:37
transparency of (real) pharmaceutical costs
-
35:50
potential barriers to innovation and patient consumer choice (panel session)
-
1:03:34
dan ollendorf. value assessment in the us. 17.12.2020.